Skip to main content
ICBII Announces Approval of Its 7th Patent on Blood-Brain Barrier Permeable Technology, Moving Closer to Clinical Trials on its drugs for Alzheimer’s, Parkinson’s, and Other Neuro-Degenerative Diseases Press Releases

ICBII Announces Approval of Its 7th Patent on Blood-Brain Barrier Permeable Technology, Moving Closer to Clinical Trials on its drugs for Alzheimer’s, Parkinson’s, and Other Neuro-Degenerative Diseases

NEWS PROVIDED BY Innovative California Biosciences International, Inc.  Sep 22, 2021, 20:26 ET LA JOLLA,…
ICBII
September 22, 2021
2019 Market Report: Novel Technologies for Delivery of Proteins, Antibodies and Nucleic Acids, 2019-2030 Press Releases

2019 Market Report: Novel Technologies for Delivery of Proteins, Antibodies and Nucleic Acids, 2019-2030

ICBII Interview Transcript-Chapter 12.3.2 and Globe Newswire, March 29, 2019 https://www.globenewswire.com/news-release/2019/03/29/1788328/0/en/2019-Market-Report-Novel-Technologies-for-Delivery-of-Proteins-Antibodies-and-Nucleic-Acids-Forecast-to-2030.html Ram Bhatt CEO, Chairman…
admin
March 29, 2019
Close Menu